Advanced therapies continue to grow in rheumatology. Today, Arthur and Sarah discuss JAK Kinase inhibitors (like upadacitinib, baricitinib, tofacitinib), a relatively new treatment for inflammatory arthritis over the last 10 years. Learn how they work, which conditions, and any safety concerns.
-----Follow us here and elsewhere too:
AlbertaRheumatology.com
Youtube: Alberta Rheumatology
-----
The information in this podcast is presented for information purposes only. For your own health needs, always check with your healthcare team to ensure you receive the best and proper care for your health conditions.